1-11 of 11
Luca Sigalotti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 202: Spry1 targeting enhances E-cadherin expression in cutaneous melanoma

Free
Barbara Montico, Giorgio Giurato, Roberto Guerrieri, Annamaria Salvati, Francesca Colizzi, Lorena Baboci, Luca Sigalotti, Alessia Covre, Michele Maio, Agostino Steffan, Tuula Anneli Nyman, Alessandro Weisz, Maurizio Mongiat, Eva Andreuzzi, Elisabetta Fratta
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 202.
https://doi.org/10.1158/1538-7445.AM2024-202
Published: 22 March 2024
View article titled, Abstract 202: Spry1 targeting enhances E-cadherin expression in cutaneous melanoma
Journal Articles

Abstract 4806: Spry1 as a potential new hypoxia modulator in cutaneous melanoma

Free
Barbara Montico, Giorgio Giurato, Roberto Guerrieri, Annamaria Salvati, Francesca Colizzi, Lorena Baboci, Luca Sigalotti, Alessia Covre, Michele Maio, Agostino Steffan, Tuula A. Nyman, Alessandro Weisz, Maurizio Mongiat, Eva Andreuzzi, Elisabetta Fratta
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4806.
https://doi.org/10.1158/1538-7445.AM2023-4806
Published: 04 April 2023
View article titled, Abstract 4806: Spry1 as a potential new hypoxia modulator in cutaneous melanoma
Journal Articles

Abstract 1005: LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer

Free
Mariateresa Casarotto, Valentina Lupato, Giorgio Giurato, Roberto Guerrieri, Sandro Sulfaro, Annamaria Salvati, Elisa D'Angelo, Carlo Furlan, Anna Menegaldo, Lorena Baboci, Barbara Montico, Irene Turturici, Riccardo Dolcetti, Salvatore Romeo, Vittorio Baggio, Stefania Corrado, Gianluca Businello, Maria Guido, Alessandro Weisz, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Luca Sigalotti, Emanuela Vaccher, Paolo Boscolo-Rizzo, Jerry Polesel, Giuseppe Fanetti, Elisabetta Fratta
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 1005.
https://doi.org/10.1158/1538-7445.AM2023-1005
Published: 04 April 2023
View article titled, Abstract 1005: LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer
Journal Articles

Abstract B06: Loss of SPRY1 expression in BRAF-mutant cutaneous melanoma inhibits cell proliferation and improves response to targeted therapy

Free
Barbara Montico, Giorgio Giurato, Francesca Colizzi, Alessia Covre, Elisa Comaro, Eliana Pivetta, Dania Benedetti, Alessandro Weisz, Agostino Steffan, Michele Maio, Luca Sigalotti, Elisabetta Fratta
Journal: Cancer Research
Cancer Res (2020) 80 (19_Supplement): B06.
https://doi.org/10.1158/1538-7445.MEL2019-B06
Published: 02 October 2020
View article titled, Abstract B06: Loss of SPRY1 expression in BRAF-mutant cutaneous melanoma inhibits cell proliferation and improves response to targeted therapy
Journal Articles

Abstract 1794: Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy

Free
Barbara Montico, Francesca Colizzi, Giorgio Giurato, Aurora Rizzo, Annamaria Salvati, Lorena Baboci, Dania Benedetti, Eliana Pivetta, Alessia Covre, Michele Dal Bo, Alessandro Weisz, Agostino Steffan, Michele Maio, Luca Sigalotti, Elisabetta Fratta
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1794.
https://doi.org/10.1158/1538-7445.AM2020-1794
Published: 15 August 2020
View article titled, Abstract 1794: Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy
Journal Articles

Abstract CT059: Epigenetic tumor remodelling to improve the efficacy of immune checkpoint blockade: the NIBIT-M4 clinical trial

Free
Anna M. Di Giacomo, Alessia Covre, Francesca Finotello, Dietmar Rieder, Luca Sigalotti, Carolina Fazio, Ornella Cutaia, Christoph Bock, Florent Petitprez, Laetitia Lacroix, James N. Lowder, Wolf H. Fridman, Catherine Sautès-Fridman, Zlatko Trajanoski, Michele Maio
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT059.
https://doi.org/10.1158/1538-7445.AM2018-CT059
Published: 01 July 2018
View article titled, Abstract CT059: Epigenetic tumor remodelling to improve the efficacy of immune checkpoint blockade: the NIBIT-M4 clinical trial
Journal Articles

Abstract 1196: Epigenetic drugs modulate long noncoding RNAs expression in BRAF inhibitor-resistant melanoma

Free
Barbara Montico, Giorgio Giurato, Katy Mastorci, Aurora Rizzo, Maria Ravo, Francesca Rizzo, Alessandro Weisz, Riccardo Dolcetti, Francesca Colizzi, Luca Sigalotti, Elisabetta Fratta
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1196.
https://doi.org/10.1158/1538-7445.AM2017-1196
Published: 01 July 2017
View article titled, Abstract 1196: Epigenetic drugs modulate long noncoding RNAs expression in BRAF inhibitor-resistant melanoma
Journal Articles

Abstract 680: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent, in hematologic malignancies.

Free
Alessia Covre, Giulia Parisi, Hugues Jmg Nicolay, Ester Fonsatti, Elisabetta Fratta, Luca Sigalotti, Pietro Taverna, Sandra Coral, Michele Maio
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 680.
https://doi.org/10.1158/1538-7445.AM2013-680
Published: 15 April 2013
View article titled, Abstract 680: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent, in hematologic malignancies.
Journal Articles

Abstract 5143: ABCG2 is involved in self renewal of melanoma cancer/initiating cells and major tumor associated antigens are expressed by ABCG2-positive cells

Free
Caterina Am La Porta, Luca Sigalotti, Alessia Covre, Beatrice Arosio, Stefania Pirroni, Maria R. Nicotra, Rouzbeh Taghizadeh, Michele Maio, James Sherley, PierGiorgio Natali
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5143.
https://doi.org/10.1158/1538-7445.AM10-5143
Published: 15 April 2010
View article titled, Abstract 5143: ABCG2 is involved in self renewal of melanoma cancer/initiating cells and major tumor associated antigens are expressed by ABCG2-positive cells
Journal Articles

5-AZA-2′-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man Story

Free
Sandra Coral, Luca Sigalotti, Alessia Covre, Hugues J.M. Nicolay, Pier Giorgio Natali, Michele Maio
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2900.
https://doi.org/10.1158/0008-5472.CAN-06-2986
Published: 15 March 2007
View article titled, 5-AZA-2′-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man Story
Open the PDF for 5-AZA-2′-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man Story in another window
Journal Articles

Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine

Free
Luca Sigalotti, Elisabetta Fratta, Sandra Coral, Silvia Tanzarella, Riccardo Danielli, Francesca Colizzi, Ester Fonsatti, Catia Traversari, Maresa Altomonte, Michele Maio
Journal: Cancer Research
Cancer Res (2004) 64 (24): 9167–9171.
https://doi.org/10.1158/0008-5472.CAN-04-1442
Published: 16 December 2004
View article titled, Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine
Open the PDF for Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine in another window